You appear to be offline. Some data may be unavailable until your connection is restored.
Description
Eli Lilly and Company is a global pharmaceutical firm that discovers, develops, manufactures and markets branded prescription medicines, with major product lines in diabetes and obesity (e.g., tirzepatide‑based drugs), oncology, immunology, neuroscience and other specialty‑care areas. The company generates revenue primarily from unit sales of these drugs to hospitals, pharmacies and healthcare providers, supported by extensive research‑and‑development investment and a worldwide commercial network. Operating in the healthcare/pharmaceutical sector, Lilly is one of the world’s largest drug manufacturers and holds a leading market share in insulin and several high‑growth therapeutic categories, recognized for a strong pipeline and significant R&D capabilities.
Stay on top of LLY news
Subscribe to LLY for a personalized daily news feed and a morning digest delivered to your inbox, plus alerts when its coverage turns bullish or bearish. For information only, not a recommendation.